Uganda has begun a trial vaccination programme for the strain of Ebola viral infection that is behind the country's latest outbreak, according to the World Health Organization (WHO), while the number of confirmed cases has risen to three.

Ugandan authorities have begun a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one person in the outbreak declared last week.

Uganda began a vaccine trial Monday against the Sudan strain of Ebola that has killed one person in the outbreak declared last week. World Health Organization Director-General Tedros Adhanom Ghebreyesus said Monday in a post on the X social media platform that the trial was “initiated

This is a critical achievement toward better pandemic preparedness and saving lives when outbreaks occur,” said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.

Ugandan officials are preparing to deploy a trial vaccine as part of efforts to stem an outbreak of Ebola in the capital, Kampala

In a global first, Uganda’s Ministry of Health, the World Health Organization (WHO) and other partners today launched a first ever vaccine trial for Ebola from the Sudan species of the virus, and at an unprecedented speed for a randomized vaccine trial in an emergency.

Uganda plans to deploy over 2,000 doses of a candidate vaccine against the Sudan strain of Ebola. View on euronews

In a related development, Ugandan scientists who sequenced the virus said they don't see a link to the country's 2022 outbreak.

Ugandan officials initiated a clinical trial on Monday for a vaccine targeting the Sudan strain of Ebola, which has resulted in one fatality since the outbreak was declared last week.

The World Health Organisation (WHO) on Monday said that it has launched a first-ever vaccine trial in Uganda for Ebola from the Sudan species of the virus.In a statement, Dr. Tedros Adhanom Ghebreyesus,